Get the latest tech news
Serbian scientists sell autoimmune disease and cancer treatment for USD 1.9 billion — Sanofi buys biopharma company Dren Bio.
Serbian scientists sell autoimmune disease and cancer treatment for USD 1.9 billion – Sanofi buys biopharma company Dren Bio
As said in a joint statement by the companies, this acquisition is a major milestone for the Serbian biotech sector and highlights the growing international recognition of innovations emerging from the region, reports bne IntelliNews. The agreement sees Sanofi acquire Dren Bio’s autoimmune disease treatment, DR-0201, a targeted bispecific myeloid cell activator. The drug, which has shown strong B-cell depletion in early clinical studies, is being investigated for a variety of autoimmune diseases and malignancies.
Or read this on r/technology